Regulation of the functional activity of the human dopamine transporter by protein kinase C

Biochemical Pharmacology

Volumn 53, Issue 5, 1997, Pages 677-688

  Zhang, Lian ^a,b   Coffey, Lori L ^a   Reith, Maarten E A ^a,c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

dopamine translocation; dopamine transporter; phosphorylation; protein kinase C; WIN 35,428 binding

Indexed keywords

CHELERYTHRINE; DOPAMINE TRANSPORTER; OKADAIC ACID; PHORBOL ESTER; PROTEIN KINASE C; STAUROSPORINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOCHEMISTRY; DOPAMINE UPTAKE; GENE EXPRESSION REGULATION; GLIOMA CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

CARRIER PROTEINS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; OKADAIC ACID; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN KINASE C; TETRADECANOYLPHORBOL ACETATE;

EID: 0030936222     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00898-2     Document Type: Article

References (63)

1. Uhl GR and Johnson PS, Neurotransmitter transporters: Three important gene families for neuronal function. J Exp Biol 196: 229-236, 1994.
2. Garris PA, Ciolkowski EL, Pastore P and Wightman RM, Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci 14: 6084-6093, 1994.
3. Giros B, Jaber M, Jones SR, Wightman RM and Caron MG, Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612, 1996.
4. Ritz MC, Lamb RJ, Goldberg SR and Kuhar MJ, Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223, 1987.
5. Pifl C, Giros B and Caron MG, Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J Neurosci 13: 4246-4253, 1993.
6. Uhl GR, Walther D, Mash D, Faucheux B and Javoy-Agid F, Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons. Ann Neurol 35: 494-498, 1994.
7. Bannon MJ, Granneman JG and Kapatos G, The dopamine transporter. Potential involvement in neuropsychiatrie disorders. In: Psychopharmacology: The Fourth Generation of Progress (Eds. Bloom FE and Kupfer DJ), pp. 179-188. Raven Press, New York, 1995.
8. Daniels J, Williams J, Asherson P, McGuffin P and Owen M, No association between schizophrenia and polymorphisms within the genes for debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter (DAT). Am J Med Genet 60: 85-87, 1995.
9. Seeman P and Niznik HB, Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J 4: 2737-2744, 1990.
10. + on the initial rates of noradrenaline uptake by synaptosomes prepared from rat brain. Biochim Biophys Acta 266: 116-127, 1972.
11. Hendley ED, Whittemore SR, Chaffee JE and Ehrlich YH, Regulation of norepinephrine uptake by adenine nucleotides and divalent cations: Role for extracellular protein phosphorylation. J Neurochem 50: 263-273, 1988.
12. Hardwick JC, Ehrlich YH and Hendley ED, Extracellular ATP stimulates norepinephrine uptake in PC12 cells, J Neurochem 53: 1512-1518, 1989.
13. Myers CL, Lazo JS and Pitt BR, Translocation of protein kinase C is associated with inhibition of 5-HT uptake by cultured endothelial cells. Am J Physiol 257: L253-L258, 1989.
14. Anderson GM and Home WC, Activators of protein kinase C decrease serotonin transport in human platelets. Biochim Biophys Acta 1137: 331-337, 1992.
15. Cool DR, Leibach FH, Bhalla VK, Mahesh VB and Ganapathy V, Expression and cyclic AMP-dependent regulation of a high affinity serotonin transporter in the human placental choriocarcinoma cell line (JAR). J Biol Chem 266: 15750-15757, 1991.
16. Ramamoorthy S, Cool DR, Mahesh VB, Leibach FH, Melikian HE, Blakely RD and Ganapathy V, Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. J Biol Chem 268: 21626-21631, 1993.
17. Corey JL, Davidson N, Lester HA, Brecha N and Quick MW, Protein kinase C modulates the activity of a cloned γ-aminobutyric acid transporter expressed in Xenopus oocytes via regulated subcellular redistribution of the transporter. J Biol Chem 269: 14759-14767, 1994.
18. Osawa I, Saito N, Koga T and Tanaka C, Phorbol esterinduced inhibition of GABA uptake by synaptosomes and by Xenopus oocytes expressing GABA transporter (GAT1). Neurosci Res 19: 287-293, 1994.
19. Tian Y, Kapatos G, Granneman JG and Bannon MJ, Dopamine and gamma-aminobutyric acid transporters: Differential regulation by agents that promote phosphorylation. Neurosci Lett 173: 143-146, 1994.
20. Giros B and Caron MG, Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14: 43-49, 1993.
21. Kadowaki K, Hirota K, Koike K, Ohmichi M, Kiyama H, Miyake A and Tanizawa O, Adenosine 3′,5′-cyclic monophosphate enhances dopamine accumulation in rat hypothalamic cell culture containing dopaminergic neurons. Neuroendocrinology 52: 256-261, 1990.
22. Kitayama S, Dohi T and Uhl GR, Phorbol esters alter functions of the expressed dopamine transporter. Eur J Pharmacol 268: 115-119, 1994.
23. Boja JW, Cline EJ, Carroll FI, Lewin AH, Philip A, Dannals R, Wong D, Scheffel U and Kuhar MJ, High potency cocaine analogs: Neurochemical, imaging, and behavioral studies. Ann NY Acad Sci 654: 282-291, 1992.
24. 3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane. Mol Pharmacol 36: 518-524, 1989.
25. 3H]WIN 35,428 binding to the dopamine uptake carrier. I. Effect of tonicity and buffer composition. J Neurosci Methods 51: 23-30, 1994.
26. Reith MEA, de Costa B, Rice KC and Jacobson AE, Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935, and dopamine to the dopamine transporter. Eur J Pharmacol 227: 417-425, 1992.
27. 3H]mazindol binding sites from alkylation by N-ethylmaleimide. Eur J Pharmacol 227: 411-415, 1992.
28. Saadouni S, Refahi-Lyamani F, Costentin J and Bonnet JJ, Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier. Eur J Pharmacol 268: 187-197, 1994.
29. Reith MEA and Selmeci G, Radiolabeling of dopamine uptake sites in mouse striatum: Comparison of binding sites for cocaine, mazindol, and GBR 12935. Naunyn Schmiedebergs Arch Pharmacol 345: 309-318, 1992.
30. 3H]GBR 12,935 binding. Mol Pharmacol 45: 125-135, 1994.
31. Eshleman AJ, Neve RL, Janowsky A and Neve KA, Characterization of a recombinant human dopamine ,transporter in multiple cell lines. J Pharmacol Exp Ther 274: 276-283, 1995.
32. Eshleman AJ, Henningsen RA, Neve KA and Janowsky A, Release of dopamine via the human transporter. Mol Pharmacol 45: 312-316, 1994.
33. Xu C, Coffey LL and Reith MEA, Translocation of dopamine and binding of 2β-carbomethoxy-3 β-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers. Biochem Pharmacol 49: 339-350, 1995.
34. Reith MEA, Xu C, Zhang L and Coffey LL, Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter. Naunyn Schmiedebergs Arch Pharmacol 354: 295-304, 1996.
35. Munson PJ and Rodbard D, LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107: 220-239, 1980.
36. De Lean A, Munson PJ and Rodbard D, Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235: E97-E102, 1978.
37. Rudnick G and Clark J, From synapse to vesicle: The reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144: 249-263, 1993.
38. Mantel J-C, Cerruti C, Fleckenstein A, Carroll FI, Kuhar MJ and Patel AP, Turnover of rat dopamine transporter protein in rDAT-LLC-PK1 cells: Use of an irreversible ligand (RTI-76) and antisense oligonucleotides. Soc Neurosci Abstr 21: 376, 1996.
39. Huang KP, The mechanism of protein kinase C activation.
40. Herbert JM, Augereau JM, Gleye J and Maffrand JP, Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172: 993-999, 1990.
41. Gschwendt M, Leibersperger H, Kittstein W and Marks F, Protein kinase Cζ and η in murine epidermis. TPA induces down-regulation of PKCη but not PKCζ. FEBS Lett 307: 151-155, 1992.
42. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D and Schachtele C, Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268: 9194-9197, 1993.
43. Gschwendt M, Furstenberger G, Leibersperger H, Kittstein W, Lindner D, Rudolph C, Barth H, Kleinschroth J, Marme D and Schachtele C, Lack of an effect of novel inhibitors with high specificity for protein kinase C on the action of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate on mouse skin in vivo. Carcinogenesis 16: 107-111, 1995.
44. Girault J-A, Protein kinases and phosphatases. Neurotransmissions 10: 1-6, 1996.
45. Bugnon O, Ofori S and Schorderet M, Okadaic acid modulates exocytotic and transporter-dependent release of dopamine in bovine retina in vitro. Naunyn Schmiedebergs Arch Pharmacol 351: 53-59, 1995.
46. Simpson IA and Cushman SW, Hormonal regulation of mammalian glucose transport. Annu Rev Biochem 55: 1059-1089, 1986.
47. Pappas CA and Ransom BR, Depolarization-induced alkalinization (DIA) in rat hippocampal astrocytes. J Neurophysiol 72: 2816-2826, 1994.
48. Koller H, Buchholz J and Siebler M, Bacterial endotoxins impair electrophysiological properties of cultured astrocytes but not of cultured neurons. J Neurol Sci 124: 156-162, 1994.
49. Deitmer JW and Schlue WR, An inwardly directed electrogenic sodium-bicarbonate co-transport in leech glial cells. J Physiol (Lond) 411: 179-194, 1989.
50. +-dependent paranitrophenylphosphatase in rat sciatic nerve fibers. Eur J Morphol 33: 247-255, 1995.
51. + antiport is activated by serum and phorbol esters in proliferating myoblasts but not in differentiated myotubes. Properties of the activation process. J Biol Chem 260: 8008-8013, 1985.
52. Koester J, Membrane potential. In: Principles of Neural Science (Eds. Kandel ER, Schwartz JH and Jessel TM), pp. 81-94. Elsevier, New York, 1996.
53. 3H]tropane to the dopamine uptake carrier. J Neurochem 61: 167-177, 1993.
54. Kitayama S, Shimada S, Xu H, Markham L, Donovan DM and Uhl GR, Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci USA 89: 7782-7785, 1992.
55. Kitayama S, Shimada S, Donovan D and Uhl G, Dopamine transporter residues important for substrate transport and ligand recognition. Soc Neurosci Abstr 18: 1331, 1992.
56. Giros B, Wang YM, Suter S, McLeskey SB, Pifl C and Caron MG, Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 269: 15985-15988, 1994.
57. Buck KJ and Amara SG, Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc Natl Acad Sci USA 91: 12584-12588, 1994.
58. Christensen NH, Biological Transport. W. A. Benjamin, Inc., London, 1975.
59. 1) and desipramine binding by amiloride and ethylisopropylamiloride. Naunyn Schmiedebergs Arch Pharmacol 340: 495-501, 1989.
60. Giambalvo CT, Protein kinase C and dopamine transport - 2. Effects of amphetamine in vitro. Neuropharmacology 31: 1211-1222, 1992.
61. Schuldiner S, Steiner-Mordoch S, Yelin R, Wall SC and Rudnick G, Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Mol Pharmacol 44: 1227-1231, 1993.
62. Asaoka Y, Nakamura S, Yoshida K and Nishizuka Y, Protein kinase C, calcium and phospholipid degradation. Trends Biochem Sci 17: 414-417, 1992.
63. Zhang L and Reith MEA, Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway. Eur J Pharmacol 315: 345-354, 1996.